Low-dose COVID-19 vaccine approved for children 5-11
The U.S. Centers for Disease Control and Prevention announced Tuesday emergency use authorization of a low-dose COVID-19 vaccine made by Pfizer-BioNTech for children ages 5-11. The move expands vaccine eligibility…